Sunglasses Are PPE. Your Frames Are a Medical Device. Selling Eyewear Into Europe in 2026.

Most merchants meet EU product compliance in the worst possible way: a marketplace suspends a listing, or a customs broker asks for a Declaration of Conformity nobody has, and the scramble starts. The reflex is to go looking for a GPSR checklist.

For an eyewear store, that reflex sends you to the wrong regulation for most of your catalogue.

The General Product Safety Regulation is the EU’s residual consumer safety law. Article 2(1) says so in terms: it applies to products “insofar as there are no specific provisions with the same objective under Union law.” Where a specific regime already governs a product’s safety, that regime wins and GPSR fills the gaps.

Eyewear has two specific regimes, and between them they cover almost everything an optical store sells:

• Non-prescription sunglasses sit under the PPE Regulation — Regulation (EU) 2016/425, category I, the low-risk tier.
• Corrective frames, corrective lenses, ready-to-wear readers and contact lenses sit under the Medical Device Regulation — Regulation (EU) 2017/745.

That is the part generic guidance gets wrong, and it is worth being blunt about it: a spectacle frame intended to carry corrective lenses is a medical device, not a general consumer product. So is the lens. So is the pair of €12 readers on your accessories page. If your compliance plan is “add four GPSR fields to the product template,” you have planned for the smallest regime that applies to you.

Here is the version written for this category. It is general information rather than legal advice, and the classification questions in particular deserve a professional answer for your specific catalogue.

Part 1: The MDR half of your catalogue

Guidance for the optical sector from ECOO, the European Council of Optometry and Optics, sets out the classifications directly:

• Corrective spectacle frames — Class I medical device.
• Corrective ophthalmic lenses — Class I.
• Contact lenses, corrective and plano — Class IIa.
• Contact lens solutions — Class IIb.

Class I is the self-certification tier: you compile a technical file, draw up a Declaration of Conformity and affix the CE mark without a notified body. Class IIa and IIb are not. If you are manufacturing or private-labelling contact lenses or solutions, a notified body is in your future, and that is a different order of project entirely.

Ready-to-wear reading spectacles are in scope too, and the EU has now said so in a regulation rather than in guidance. Commission Delegated Regulation (EU) 2025/1920 of 12 June 2025 amends Annex VI of the MDR to create a Master UDI-DI scheme for exactly three product families: spectacle frames, spectacle lenses, and ready-to-wear reading spectacles. The Commission’s Medical Device Coordination Group published implementing guidance, MDCG 2025-8 Rev. 1, in March 2026. More on the deadline in Part 6 — the point here is that the legislator has named readers as devices in black and white.

And the coloured-lens question has an answer. Cosmetic contact lenses with no corrective power used to sit in a grey area. They do not any more: MDR Annex XVI pulls in products without an intended medical purpose, and group 1 of that Annex is “contact lenses or other items intended to be introduced into or onto the eye.” Common specifications for those products came through Regulation (EU) 2022/2346, applicable since 22 June 2023, with longer transitional deadlines only where a notified body is involved. A plano coloured lens is regulated as a device because of where it goes, not because of what it corrects.

Part 2: The question that actually decides your obligations

Almost every eyewear retailer asks the wrong first question — “is this a medical device?” — when the one that determines the size of the job is: are you a distributor or a manufacturer?

The answer turns on a narrow point, and it is the most useful thing in this article.

Under the Member States’ guidance on adaptable medical devices (MDCG 2021-3), a person who adapts, adjusts, assembles or shapes an adaptable medical device is not regarded as a manufacturer but a distributor — provided two conditions hold. Every component must be CE-marked, and the assembly must follow the manufacturer’s instructions. Glaze a CE-marked lens into a CE-marked frame, the way the lens maker says to, and you are a distributor. That is a real set of obligations — Article 14 MDR, verifying CE marking and the Declaration of Conformity, storage and transport conditions, complaint handling, passing incident reports up the chain — but it is a set a competent retailer can meet.

Step outside those two conditions and the ground moves. Use a component that is not CE-marked, or depart from the instructions, and you become the manufacturer of a custom-made device, with risk management, clinical evaluation, post-market surveillance and the documentation to prove all three. Nobody plans to cross that line. Stores cross it by sourcing an uncertified frame from a supplier who was cheap and vague.

So the diligence that matters is not a metafield audit. It is a supplier audit: can every frame and lens line in your catalogue produce a CE mark and a Declaration of Conformity, in writing? If a supplier cannot, you are not looking at a paperwork gap. You are looking at a change in what you legally are.

Part 3: The PPE half — sunglasses

Non-prescription sunglasses for general use are treated as personal protective equipment in category I under Regulation (EU) 2016/425, with EN ISO 12312-1 as the relevant harmonised standard. CE marking, a Declaration of Conformity and a technical file; UV protection and luminous transmittance are the tests that matter, and filter category (0–4) has to be right and declared. If you are buying finished goods, your supplier should be able to hand you test reports and a DoC. If they cannot, that is your answer about the supplier. This paragraph is about plano sunglasses only and does not extend to prescription lenses, which are on the MDR side of the line described above.

Note the second-order consequence, because it changes what you may say in your marketing. Because UV filtering to the standard is a condition of sale rather than a feature, presenting it as a distinctive selling point is separately prohibited from 27 September 2026 under the EmpCo directive. We covered that date and what it bans in detail here. Compliance over here and advertising law over there are describing the same fact from two directions.

Safety and industrial eyewear is a different world again: EN 166 for personal eye protection and EN 172 for industrial sun-glare filters, with higher PPE categories, impact-resistance testing and notified-body involvement depending on the risk class. If you sell prescription safety glasses, you are in both regimes at once and neither set of paperwork covers the other. Verify the current version of each standard before you name it on a page.

Part 4: What GPSR still requires, and why the listing rules still bite

None of the above means you can ignore GPSR. Medical devices are not in the Article 2(2) exclusion list — the carve-out in Article 2(1) is about overlap, not immunity, and GPSR still reaches aspects and risks the specific regimes do not cover. More practically: the online listing requirements are what marketplaces check automatically, and they are the reason listings get suspended.

The legal hook is Article 19, “obligations of economic operators in the case of distance sales.” An online offer must clearly and visibly indicate:

1. The manufacturer’s name, registered trade name or trade mark, and postal and electronic address.
2. Where the manufacturer is not established in the Union, the responsible person’s name and postal and electronic address.
3. Information identifying the product, including a picture of it, its type and any other product identifier.
4. Any warning or safety information to be affixed to the product, its packaging or an accompanying document, in a language consumers can easily understand.

“Clearly and visibly” means on the product page, not in a PDF a customer would have to request. Shopify’s own merchant guidance suggests handling warnings through the Disclosures product metafield and metaobject entries, with the rest in product descriptions or custom metafields. There is no native Responsible Person tooling — that is an arrangement you make outside the platform.

For a store with 400 SKUs this is a metafield schema and a bulk edit, not a per-product afternoon. Do it once, structured, or you will be doing it forever.

The Responsible Person, which is the one that bites

If you are a UK, US or Asian seller shipping eyewear to EU consumers and no economic operator in your chain is established in the EU, you cannot lawfully place those products on the EU market. GPSR Article 16 requires one, and it borrows the list from the Market Surveillance Regulation (EU) 2019/1020: an EU manufacturer, importer, authorised representative or fulfilment service provider. One entity can hold the role for both regimes.

Two practical notes. It cannot be a mailbox — the role carries real obligations and a real address, and nominee services vary enormously in whether they will actually perform it. And their details go on the listing and, where required, on the product or packaging. This is the field the marketplaces parse, which is why suspensions cluster here.

Part 5: Stock that predates the rules

This question comes up constantly from anyone clearing old inventory, and in 2026 a German court gave the first reported answer to it.

GPSR Article 51 is a transitional provision for products lawfully placed on the EU market before 13 December 2024. In interim injunction proceedings reported at the end of July 2026, the Landgericht Berlin II (case reference reported as 101 O 10/25 eV) refused an application by a competitor against an online seller, on the basis that goods demonstrably placed on the market before that date may continue to be offered without the seller retrofitting the new GPSR information onto the listing. The reasoning that makes the outcome make sense: the predecessor product safety rules required manufacturer markings on the product, but never required that information to appear in an online listing — so there was no pre-existing duty for the new one to continue.

Three cautions, and they matter more than the headline.

It is an interim decision, not a judgment. The eV in the case reference marks it as injunction proceedings. It is first instance, no full text appears to have been published in any judgment database, the decision date is not reported, and it is open to challenge. Treat it as an indication of how one court read Article 51, not as settled law.

Article 51 attaches to the individual unit, not to the product line. This is where merchants will get themselves into trouble. The transitional provision covers the specific goods placed on the market before 13 December 2024 — not the model, not the SKU, and not the fact that you were selling that frame in 2023. To rely on it you must be able to evidence that the stock in front of you predates the cutoff. Most stores cannot.

It changes nothing about new stock, and nothing at all about the MDR. Everything imported since December 2024 needs the full Article 19 listing set. And a transitional provision in the GPSR has no effect on a device regime it does not govern.

Part 6: The 2028 date nobody has in a calendar yet

Delegated Regulation (EU) 2025/1920 introduces the Master UDI-DI, a grouping identifier designed for what the MDR calls highly individualised devices — products where per-variant identification would produce millions of codes. Instead of a UDI for every dioptre and every frame width, manufacturers group by defined design parameters: frame construction and material with horizontal boxed lens size as the master parameter; for lenses, refractive index and design type with spherical equivalent and addition power ranges; for readers, lens size and spherical power. Brand names, model references and catalogue numbers do not trigger a new identifier.

It applies from 1 November 2028, with voluntary early assignment permitted, and devices produced before that date do not need Master UDI-DI labelling.

The obligation sits on manufacturers, not retailers. It is on this list for two reasons. If you private-label — and a great many online eyewear brands do — then you may be the manufacturer and this is your deadline. And if you do not, it is still the question to put to your suppliers in 2027, because a supplier who has never heard of it in 2028 is a supply problem you will discover at the worst moment.

Part 7: The UK is two regimes, and one of them is unfinished

Great Britain is not a rounding error on an EU compliance plan.

For the medical device side, GB has a functioning regime and it has teeth. A manufacturer based outside the UK must appoint a UK Responsible Person, and devices must be registered with the MHRA before being placed on the GB market. That is a second Responsible Person, separate from your EU one. CE marking is accepted under transitional arrangements rather than indefinitely: devices certified under the EU MDR are currently accepted in Great Britain until 30 June 2030, and devices under the older Medical Devices Directive until 30 June 2028, or certificate expiry if sooner.

For the general consumer product side, GB is mid-rebuild. The Product Regulation and Metrology Act 2025 received Royal Assent on 21 July 2025, but it is enabling legislation — it grants powers to make regulations rather than making substantive change itself. The detail arrives in secondary legislation that had not landed as of early 2026. Plan for divergence from the EU rather than assuming alignment, and do not assume a GPSR-compliant listing is automatically a GB-compliant one.

Northern Ireland follows different rules again.

Part 8: The compliance work that also sells glasses

Almost everything above is pure cost. Three parts of it are not.

Filter category and UV data on the page. You have to determine it anyway for the DoC. Putting “Category 3 — 100% UVA/UVB, 8–18% light transmission” on the product page instead of leaving it in a file is a compliance artefact that reads as product expertise. State it as a specification, not as a boast — see the EmpCo note in Part 3.

Structured product data. Article 19 pushes you towards holding identifiers, manufacturer details and safety attributes as structured fields rather than prose. That same structure is what makes your catalogue legible to comparison surfaces and AI shopping agents. You are being made to do the data hygiene that was already the right idea.

The CE and DoC audit is a quality signal you can use. A supplier that produces a Declaration of Conformity within a day is a supplier you can build on. One that goes quiet has told you something you needed to know anyway.

And the prescription flow, separately. Prescription data is health data under GDPR Article 9 whatever the product classification says. If you capture prescriptions from EU customers you need explicit consent, data minimisation, a defined retention period and a processor agreement with any vendor that touches it. That obligation is independent of everything above and applies from your first EU order. It sits alongside the other face-and-body data obligations an eyewear store has picked up recently — the biometric rules around virtual try-on are a separate regime with the same underlying lesson.

The 60-minute version

1. Split your catalogue into the two regimes. Plano sunglasses in the PPE column; corrective frames, lenses, readers and contact lenses in the MDR column. Most stores have never written this down, and the GPSR checklist they have been working from does not fit either column.
2. Ask every frame and lens supplier, in writing, for the CE marking evidence and Declaration of Conformity. This is the one that decides whether you are a distributor or a manufacturer. Do it first.
3. Confirm whether you have an EU Responsible Person. If the answer is “I’m not sure,” the answer is no. If you sell into Great Britain and your catalogue includes devices, check whether you also need a UK Responsible Person and MHRA registration.
4. Add the Article 19 fields to your product template — manufacturer identity and addresses, responsible person, product identifier, warnings — and backfill by bulk edit rather than by hand.
5. Work out whether any stock genuinely predates 13 December 2024 and whether you could prove it at unit level. If not, Article 51 is not available to you.
6. Put 1 November 2028 in the calendar if you private-label, and in your 2027 supplier questions if you do not.
7. Check your prescription data handling against GDPR Article 9, separately from all of the above.

None of this will show up in your conversion rate. What it does is remove the failure mode where a listing is pulled, a shipment is held, or an authority asks a question you cannot answer — each of which costs more in a week than the compliance work costs in a year.

Frequently asked questions

Are spectacle frames medical devices in the EU?
Frames intended to carry corrective lenses are treated as Class I medical devices under Regulation (EU) 2017/745, as are corrective ophthalmic lenses. Contact lenses, corrective and plano, are Class IIa. Ready-to-wear reading spectacles are named as devices in Delegated Regulation (EU) 2025/1920.

Are sunglasses PPE in the EU?
Non-prescription sunglasses for general use are generally treated as personal protective equipment in the lowest risk category under Regulation (EU) 2016/425, requiring CE marking, a Declaration of Conformity and a technical file, with EN ISO 12312-1 as the relevant harmonised standard.

Does GPSR apply to eyewear at all?
Article 2(1) makes GPSR residual: it applies insofar as there are no specific provisions with the same objective under Union law. For most of an optical catalogue the specific regime is the Medical Device Regulation or the PPE Regulation. GPSR still reaches aspects those regimes do not cover, and its Article 19 distance-selling requirements are what marketplaces check.

If I glaze lenses into frames, am I a manufacturer?
Under the Member States’ guidance on adaptable medical devices, assembling CE-marked components in accordance with the manufacturer’s instructions makes you a distributor rather than a manufacturer. Using components that are not CE-marked, or departing from those instructions, can make you the manufacturer of a custom-made device, with substantially heavier obligations.

Do I need an EU Responsible Person to sell eyewear into the EU?
If no economic operator in your supply chain is established in the EU, yes — GPSR Article 16 requires one before the product can be placed on the EU market, and their details must appear in the online offer. Selling devices into Great Britain raises a separate question about a UK Responsible Person and MHRA registration.

Does GPSR apply to stock I was already selling before December 2024?
Article 51 is a transitional provision for products lawfully placed on the EU market before 13 December 2024, and a Berlin regional court declined in July 2026, in interim proceedings, to require a seller to retrofit the new requirements onto such goods. It is an interim decision rather than settled law, and the provision attaches to individual units rather than to the product line — so you must be able to evidence that the specific stock predates the cutoff. Anything imported since does not benefit from it.

Is CE marking enough for the UK?
Not indefinitely. Great Britain operates the UKCA regime and accepts CE marking for medical devices only under transitional arrangements — currently to 30 June 2030 for EU MDR devices and 30 June 2028 for older Medical Devices Directive certificates. The general consumer product framework is being rebuilt under the Product Regulation and Metrology Act 2025 and its detail is still to come.

How long do I need to keep the technical file?
Ten years is the standard retention expectation. As the importer, that obligation sits with you.

---

VisioncarePro handles the prescription side of a European eyewear order — structured capture, AI reading of uploaded prescriptions with the customer confirming the values, and encrypted storage under documented controls. Free to install.

Install VisioncarePro free on the Shopify App Store →

---

This article is general information, not legal advice. Product classification under the MDR and the PPE Regulation depends on the specific product, its intended purpose and how it is supplied, and it deserves a professional answer for your own catalogue. Nothing here is a statement about the compliance status of VisioncarePro or of any merchant.

Sources: Regulation (EU) 2023/988 (General Product Safety Regulation), Articles 2, 16, 19 and 51 · Regulation (EU) 2017/745 (Medical Device Regulation) · Commission Delegated Regulation (EU) 2025/1920 of 12 June 2025 amending Annex VI of Regulation (EU) 2017/745 as regards Unique Device Identifiers for spectacle frames, spectacle lenses and ready-to-wear reading spectacles · MDCG 2025-8 Rev. 1, guidance on implementation of the Master UDI-DI solution for spectacle frames, spectacle lenses and ready-to-wear reading spectacles (March 2026) · MDCG 2021-3 on adaptable medical devices · ECOO guidance for the optical sector on the Medical Device Regulation · MDR Annex XVI and Regulation (EU) 2022/2346 (common specifications for products without an intended medical purpose) · Regulation (EU) 2016/425 (PPE Regulation) · Regulation (EU) 2019/1020 (Market Surveillance Regulation), Article 4 · Landgericht Berlin II, case reported as 101 O 10/25 eV, interim injunction proceedings, reported July 2026 (Händlerbund; etailment) · Shopify Help Center, “Understanding the General Product Safety Regulation (GPSR)” · MHRA, “Regulating medical devices in the UK” · Product Regulation and Metrology Act 2025 · EN ISO 12312-1, EN ISO 12870, EN 166, EN 172 · GDPR Article 9.